Carriage of Streptococcus pneumoniae 3 years after start of vaccination program, the Netherlands
about
Streptococcus pneumoniae carriage in the Gaza stripLong-term effects of pneumococcal conjugate vaccine on nasopharyngeal carriage of S. pneumoniae, S. aureus, H. influenzae and M. catarrhalisEffect of serotype on focus and mortality of invasive pneumococcal disease: coverage of different vaccines and insight into non-vaccine serotypesStreptococcus pneumoniae non-susceptibility and outpatient antimicrobial prescribing rates at the Alaska Native Medical CenterUsing pneumococcal carriage data to monitor postvaccination changes in invasive disease.Direct effect of 10-valent conjugate pneumococcal vaccination on pneumococcal carriage in children BrazilProtein carriers of conjugate vaccines: characteristics, development, and clinical trials.Serotype distribution and antibiotic susceptibility of Streptococcus pneumoniae strains carried by children infected with human immunodeficiency virus.Pneumococcal transmission and disease in silico: a microsimulation model of the indirect effects of vaccination.Superiority of trans-oral over trans-nasal sampling in detecting Streptococcus pneumoniae colonization in adults.High nasopharyngeal carriage of non-vaccine serotypes in Western Australian aboriginal people following 10 years of pneumococcal conjugate vaccination.Optimising assessments of the epidemiological impact in The Netherlands of paediatric immunisation with 13-valent pneumococcal conjugate vaccine using dynamic transmission modelling.Five winters of pneumococcal serotype replacement in UK carriage following PCV introductionThe serotype distribution among healthy carriers before vaccination is essential for predicting the impact of pneumococcal conjugate vaccine on invasive disease.Differential B-cell memory around the 11-month booster in children vaccinated with a 10- or 13-valent pneumococcal conjugate vaccine.Direct Comparison of Immunogenicity Induced by 10- or 13-Valent Pneumococcal Conjugate Vaccine around the 11-Month Booster in Dutch Infants.Dynamics of pneumococcal nasopharyngeal carriage in healthy children attending a day care center in northern Spain. Influence of detection techniques on the resultsRoutine infant immunization with the 7- and 13-valent pneumococcal conjugate vaccines: current perspective on reduced-dosage regimens.Effect of Serotype on Pneumococcal Competition in a Mouse Colonization ModelThe post-vaccine microevolution of invasive Streptococcus pneumoniae.Geographic variation in pneumococcal vaccine efficacy estimated from dynamic modeling of epidemiological data post-PCV7Effects of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D-conjugate vaccine on nasopharyngeal bacterial colonization in young children: a randomized controlled trial.Invasive pneumococcal disease and 7-valent pneumococcal conjugate vaccine, the Netherlands.Molecular surveillance of nasopharyngeal carriage of Streptococcus pneumoniae in children vaccinated with conjugated polysaccharide pneumococcal vaccinesNeuraminidase A-Exposed Galactose Promotes Streptococcus pneumoniae Biofilm Formation during Colonization.Molecular surveillance on Streptococcus pneumoniae carriage in non-elderly adults; little evidence for pneumococcal circulation independent from the reservoir in children.Carriage of Streptoccoccus pneumoniae in healthy adults aged 60 years or over in a population with very high and long-lasting pneumococcal conjugate vaccine coverage in children: rationale and perspectives for PCV13 implementation.Seven-valent pneumococcal conjugate vaccine and nasopharyngeal microbiota in healthy childrenPrevalent Multidrug-resistant Nonvaccine Serotypes in Pneumococcal Carriage of Healthy Korean Children Associated with the Low Coverage of the Seven-valent Pneumococcal Conjugate Vaccine.Sex differences in invasive pneumococcal disease and the impact of pneumococcal conjugate vaccination in the Netherlands, 2004 to 2015.A review of the evidence to inform pneumococcal vaccine recommendations for risk groups aged 2 years and older.Spectrum of pneumococcal serotype 11A variants results from incomplete loss of capsule O-acetylation.Population effect of 10-valent pneumococcal conjugate vaccine on nasopharyngeal carriage of Streptococcus pneumoniae and non-typeable Haemophilus influenzae in Kilifi, Kenya: findings from cross-sectional carriage studies.Avidity of antibodies against infecting pneumococcal serotypes increases with age and severity of disease.Pre-vaccine serotype composition within a lineage signposts its serotype replacement - a carriage study over 7 years following pneumococcal conjugate vaccine use in the UK.Pneumococcal immune evasion: ZmpC inhibits neutrophil influx.Nasal carriage of Streptococcus pneumoniae serotypes and Staphylococcus aureus in Streptococcus pneumoniae-vaccinated and non-vaccinated young children.Use of Multiplex Quantitative PCR To Evaluate the Impact of Pneumococcal Conjugate Vaccine on Nasopharyngeal Pneumococcal Colonization in African Children.The impact of specific and non-specific immunity on the ecology of Streptococcus pneumoniae and the implications for vaccination.Increased carriage of non-vaccine serotypes with low invasive disease potential four years after switching to the 10-valent pneumococcal conjugate vaccine in The Netherlands.
P2860
Q28482482-226F4B93-86C4-4263-A6AB-AED4557CC48FQ28728017-9ECB60DC-1A70-4283-911A-8D78116D82EFQ28729162-948A801B-94D7-4A20-8C96-61C2B94C1753Q30218061-55D9684B-AAAF-45D9-A4F3-BC535DEAEF61Q30665494-CD8FF39B-8A7C-4216-B6AA-30B58B014E93Q33706645-84BF9E74-B62E-4270-84B3-8ADF75DCDF83Q34170021-97FF6FB0-A2D2-4FD5-9CE8-8B4AD1E0F8A9Q34400566-A4C5D773-455E-4DBD-A676-248350DC18E4Q34606511-7DEE0102-1510-4363-885A-C62617A66DBCQ34654025-CDD2CB12-2A31-45E5-B6E2-69786D920629Q35070146-62223C61-6220-432D-B2D0-333B1AF8F42AQ35138184-B0516D06-100F-437C-9FA7-E782D41B3635Q35353529-A39DCD53-93E5-4480-8AF8-0E54F72135E7Q35603351-27EC9C67-CB96-4E79-9EE3-295D269C309BQ35855954-2587FBDD-4998-4F0F-AED8-C354B4B83294Q35867061-CE1180AA-5F44-4078-8F23-BA302A8BD320Q36059360-3BFABC33-B4E0-44DE-9A07-A10F278277E7Q36105725-F0E316F8-8AB9-4883-9FEB-DECFE6499F66Q36143589-D8950BAB-C32E-437D-884D-AB3044C9C8B0Q36192266-55FCA293-BE38-4835-9D72-683D006BEA63Q36399999-33040EEB-FB1F-4527-B320-F665A8A09A63Q36517800-E5D6B72A-B89F-4EF1-9A13-2B66E833E1ADQ36574279-557A6C33-7A90-4F92-AE4B-5534439AEF88Q36764806-436B1D07-41C1-485F-83CE-C14D62925EA0Q37287225-48254488-C662-46EA-B3E2-423178C53A48Q37319027-DD4ED3BE-5EF2-43DA-94A5-EA63F82EE061Q37478339-B54C0FDA-AD68-4E74-B41C-A9C61B32341FQ37513519-36302269-85A5-438E-B2EA-07EA35219A35Q37579687-045DF570-0F33-44F9-89D6-578F48134C5DQ37708522-DAC7DC28-BF2F-47DF-81BF-EC7FE1576040Q38220556-980EE309-04BA-49BA-BB49-F976FAC8930DQ38323337-858873F0-2EC1-497B-BD8C-35E1ED40C58AQ39043548-C172503D-A397-414A-ADA6-3708D41DA2ECQ40601884-41E61D74-28F5-42F7-9583-2F5215A742CCQ42278433-9B6C2213-1B9F-4EEF-850E-A9AB8AE3D16FQ43971573-919022E7-7175-485B-8B8D-AEE0D1CDE97CQ44518730-46A0C3C3-4A13-4D98-BFC6-64A08B87743BQ44521723-F5288ACA-1EE1-46A9-809B-070A415ED505Q51157834-190497BF-41FA-4C13-93C6-DAA29AC20676Q54245000-A805D1FE-90EE-4886-A8BA-A527D24C0AEE
P2860
Carriage of Streptococcus pneumoniae 3 years after start of vaccination program, the Netherlands
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Carriage of Streptococcus pneu ...... ation program, the Netherlands
@ast
Carriage of Streptococcus pneu ...... ation program, the Netherlands
@en
type
label
Carriage of Streptococcus pneu ...... ation program, the Netherlands
@ast
Carriage of Streptococcus pneu ...... ation program, the Netherlands
@en
prefLabel
Carriage of Streptococcus pneu ...... ation program, the Netherlands
@ast
Carriage of Streptococcus pneu ...... ation program, the Netherlands
@en
P2093
P2860
P356
P1476
Carriage of Streptococcus pneu ...... ation program, the Netherlands
@en
P2093
Alienke J Wijmenga-Monsuur
Arie van der Ende
Ed P F Yzerman
Elisabeth A M Sanders
Elske J M van Gils
Germie P J M van den Dobbelsteen
Judith Spijkerman
Reinier H Veenhoven
P2860
P304
P356
10.3201/EID1704.101115
P577
2011-04-01T00:00:00Z